Brainstorm seeks accelerated approval for NurOwn treatment from the FDA.
1 report, 0 independent
Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Brainstorm seeks accelerated approval for NurOwn treatment from the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Brainstorm
company in Madrid, Spain
Nothing else this week.
Related events
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- The FDA is reviewing a drug approval application for a condition involving the company GAD.
- Inventiva seeks FDA approval for lanifibranor in the U.S. market.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- The FDA recommended advancement for a new drug application submitted by a company.
Coverage
Newest first; wire copies grouped- Unknown outlet